Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease
Awarded
The competition has ended and a winner has been selected.
The European Commission, DG CNECT - Communications Networks, Content and Technology, has entered into an agreement with Huvepharma EOOD for the purchase, storage, and delivery of an estimated maximum of 2,640,000 doses of live attenuated homologous vaccine against Lumpy Skin Disease. The contract has a duration of 4 years and an estimated total value of 2,385,950 EUR. The services include an initial purchase of 528,000 doses and up to four replenishments of 528,000 doses each, storage of an initial stock of 528,000 doses readily available for delivery, timely delivery of all doses to specified destinations, storage of any remaining vaccines until the end of their shelf life, and proper destruction and disposal of unused vaccines. Five bids were received for this contract.
Result
- Winner
- Huvepharma EOOD
- Number of bids
- 5
- Contract value
- €2,385,950
About the bid
- Contact phone
- +32 2 299 11 11
- Contact email
- sante-procurement@ec.europa.eu
- Address
- CSM1, rue Père de Deken 23, B-1040 Brussels
REASON FOR PURCHASING The Commission has to maintain an estimated stock of at least 528.000 doses of live attenuated Lumpy Skin Disease (LSD) vaccine in storage in order to make it rapidly available in case it is needed. In addition, this stock of 528.000 doses of live attenuated vaccine should be replaced quickly, within 4 weeks, when depleted, in order to maintain the Union’s capability to respond to an emergency. PROCUREMENT DESCRIPTION The purpose of the contract is: • The purchase of an estimated maximum 2.640.000 doses of live attenuated homologous vaccine against LSD. This will be executed with one initial purchase of 528.000 and up to four (4) replenishments, of 528.000 doses each, upon request from the Commission. • The storage of an initial stock of 528.000 doses, readily available for delivery to any of the destinations listed in the technical specifications, that can be replaced, if depleted, partially or totally, up to 4 times until the end of the contract, upon request from the Commission. • The timely delivery of maximum 2.640.000 doses divided in as many consignments as needed to any of the destinations listed in the technical specifications • The storage of any vaccines in stock at the end of the contract for the remainder of their shelf life • The proper destruction and disposal of any unused vaccine at the end of its self life.
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Description
Please consult the procurement documents.
Description
Please consult the procurement documents.
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- European Commission, DG REGIO - Regional and Urban Policy
- Title
- Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease
- Type
- Main code
- Supplemental codes
- Estimated value
- €3,200,000.00
- Duration
- 48 months
No supplemental codes from buyer…